Silence Therapeutics (SLN) Other Gross PP&E Adjustments (2023 - 2026)
Silence Therapeutics recorded quarterly Other Gross PP&E Adjustments of -$142000.0 in Q1 2026, down 112.43% quarter-over-quarter from $1.1 million in Q4 2025, and down 32.71% year-over-year from -$211027.8 in Q1 2025.
Silence Therapeutics' Other Gross PP&E Adjustments history runs 4 years deep, the most recent figure standing at -$142000.0 for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 32.71% year-over-year to -$142000.0; the TTM figure through Mar 2026 stood at -$142000.0 (down 32.71% YoY), while the FY2025 annual figure was $1.1 million, down 54.74% from the prior year.
- Other Gross PP&E Adjustments came in at -$142000.0 for Q1 2026 at Silence Therapeutics, down from $1.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.5 million in Q4 2024 to a low of -$192000.0 in Q3 2025.
- A 4-year average of $794571.4 and a median of -$58000.0 in 2025 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments gained 5.3% in 2024 and slumped 54.74% in 2025, its largest moves.
- Silence Therapeutics' Other Gross PP&E Adjustments stood at $2.4 million in 2023, then grew by 5.3% to $2.5 million in 2024, then sank by 54.74% to $1.1 million in 2025, then sank by 112.43% to -$142000.0 in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$142000.0, $1.1 million, and -$192000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | -142,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,000.00 |
| Mar 31, 2026 | -142,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | -192,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Jun 30, 2025 | -58,000.00 |
| Jun 30, 2025 | -58,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Dec 31, 2024 | 2.52 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Dec 31, 2023 | 2.40 Mn |